These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 1438242)

  • 1. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
    Pletnev AG; Bray M; Huggins J; Lai CJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
    Pletnev AG; Bray M; Lai CJ
    J Virol; 1993 Aug; 67(8):4956-63. PubMed ID: 8331735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
    Pletnev AG; Men R
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice.
    Chen W; Kawano H; Men R; Clark D; Lai CJ
    J Virol; 1995 Aug; 69(8):5186-90. PubMed ID: 7609092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.
    Teterina NL; Maximova OA; Kenney H; Liu G; Pletnev AG
    Antiviral Res; 2016 Mar; 127():57-67. PubMed ID: 26794396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.
    Engel AR; Rumyantsev AA; Maximova OA; Speicher JM; Heiss B; Murphy BR; Pletnev AG
    Virology; 2010 Sep; 405(1):243-52. PubMed ID: 20594569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
    Heiss BL; Maximova OA; Pletnev AG
    J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.
    Engel AR; Mitzel DN; Hanson CT; Wolfinbarger JB; Bloom ME; Pletnev AG
    Vector Borne Zoonotic Dis; 2011 Jun; 11(6):665-74. PubMed ID: 21142950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome.
    Cahour A; Pletnev A; Vazielle-Falcoz M; Rosen L; Lai CJ
    Virology; 1995 Feb; 207(1):68-76. PubMed ID: 7871753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
    Bray M; Men R; Lai CJ
    J Virol; 1996 Jun; 70(6):4162-6. PubMed ID: 8648761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
    Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
    J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.